LeMaitre Vascular Inc. (LMAT)
NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LMAT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.68B
- P/E (TTM)
- 26.77
- Forward P/E
- 23.37
- EPS (TTM)
- $2.75
- Dividend yield
- 1.29% ($0.95)
- Ex-dividend date
- Nov 19, 2026
- 52-week range
- 73.44 – 118.01
- Day range
- 73.44 – 76.44
- Volume / Avg
- 313.55K / 277.19K
- Beta
- —
- Shares outstanding
- 22.88M
52-week range
LMAT stock today
LeMaitre Vascular (LMAT) closed at $73.61 on Nov 20, down 1.67% (-$1.25), versus the S&P 500's 3.70% decline. At this level, LMAT sits near the bottom of its 52-week range of $73.44 to $118.01: 37.6% below the high, set on Apr 14, 2026 and 0.2% above the low. LMAT is down 9.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 16.3%.
LeMaitre Vascular trades at 26.8x its trailing twelve-month earnings per share of $2.75. Its forward P/E of 23.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. LeMaitre Vascular pays an annual dividend of $0.95 per share, a 1.29% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About LeMaitre Vascular
Company profileLeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. George W. LeMaitre
- Headquarters
- Burlington, MA
- Employees
- 646
- IPO year
- 2006
- Website
- lemaitre.com
Financial highlights
Full financialsIn fiscal 2025, LeMaitre Vascular generated $249.6 million in revenue, up 13.5% from fiscal 2024, its 13th consecutive year of revenue growth. Net income was $57.7 million (+31.1% year over year), for a net margin of 23.1% versus a median of 16.4% in the prior 5 years. Gross margin was 71.5% (up from 68.6%) and operating margin 27.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $249.60M | $219.86M | $193.48M | $161.65M | $154.42M |
| Growth | +13.53% | +13.63% | +19.69% | +4.68% | +19.37% |
| Net income | $57.73M | $44.04M | $30.11M | $20.64M | $26.91M |
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 |
Analyst forecast
ForecastConsensus (8 analysts)
buy
Avg. price target
$99.29+34.89%
- Strong buy 2
- Buy 2
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $0.62 vs $0.69
- Surprise
- -10.14%
Dividends
Dividend history- Annual dividend
- $0.95
- Dividend yield
- 1.29%
- Last payment
- $0.25
- Ex-dividend date
- Nov 19, 2026
- Pay date
- Dec 3, 2026
LMAT news
All LMAT news- LeMaitre to Participate in Upcoming Investor ConferencesGlobeNewswire
- LeMaitre Vascular (LMAT) Q3 2026 Earnings Call TranscriptNasdaq
- LeMaitre Vascular GAAP EPS of $0.65 misses by $0.04, revenue of $68M beats by $0.63MSeeking Alpha
- LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026GlobeNewswire
LeMaitre Vascular peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XRAYDENTSPLY SIRONA Inc. | 8.29 | -2.36% | $1.65B | vs LMAT |
| INSPInspire Medical Systems Inc. | 55.10 | -2.10% | $1.60B | vs LMAT |
| KMTSKestra Medical Technologies Ltd. | 25.10 | -5.75% | $1.50B | vs LMAT |
| PRCTPROCEPT BioRobotics Corporation | 24.70 | -4.08% | $1.42B | vs LMAT |
| NVCRNovoCure Limited | 10.71 | +0.19% | $1.25B | vs LMAT |
| TNDMTandem Diabetes Care Inc. | 17.46 | +3.93% | $1.22B | vs LMAT |
| UFPTUFP Technologies Inc. | 290.85 | -2.70% | $2.25B | vs LMAT |
| DRTSAlpha Tau Medical Ltd. | 11.76 | +3.93% | $1.09B | vs LMAT |
Indexes, lists and sector
LeMaitre Vascular stock FAQ
What is LeMaitre Vascular's stock price today?
LMAT last traded at $73.61 as of Nov 20, 4:00 PM EST, down 1.67% on the day. Prices are delayed at least 15 minutes.
Does LeMaitre Vascular pay a dividend?
Yes. LeMaitre Vascular pays $0.95 per share annually, a 1.29% yield. The most recent dividend of $0.25 had an ex-dividend date of Nov 19, 2026.
What is LMAT's P/E ratio?
LMAT trades at a trailing P/E ratio of 26.77 and a forward P/E of 23.37.
Who is LeMaitre Vascular's CEO?
Mr. George W. LeMaitre is the chief executive officer of LeMaitre Vascular Inc., which has about 646 employees.
What is the LMAT 52-week high?
The 52-week high for LMAT is $118.01 and the 52-week low is $73.44. The stock is currently 37.6% below its high.